Tumor suppression effect of ultrasound-sensitive nanoparticles with focused ultrasound in a pancreas cancer xenograft model

Tumor suppression effect of ultrasound-sensitive nanoparticles with focused ultrasound in a pancreas cancer xenograft model

Abstract Background We investigated the tumor suppression effect of an ultrasound-sensitive doxorubicin-loaded liposome-based nanoparticle, IMP301, to enhance the synergistic effect with focused ultrasound (FUS) in an animal model of pancreatic cancer. Methods Thirty nude mice with xenografts of PAN...

Full description

Bibliographic Details
Main Authors:	Soojin Kim, Jae Young Lee, Eun-Joo Park, Yun Deok Ahn, Yuri Cheon, Wonchul Sim, Hak Jong Lee
Format:	Article
Language:	English
Published:	SpringerOpen 2024-03-01
Series:	European Radiology Experimental
Subjects:	Doxorubicin Heterografts Liposomal doxorubicin Pancreatic neoplasms Ultrasonic therapy
Online Access:	https://doi.org/10.1186/s41747-024-00436-2

Similar Items

Ultrasound-Responsive Liposomes for Targeted Drug Delivery Combined with Focused Ultrasound
by: Yoon-Seok Kim, et al.
Published: (2022-06-01)

Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery
by: Huang, Bu-Wei, et al.
Published: (2018)

Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound
by: Laura Spiers, et al.
Published: (2023-09-01)

Combination Therapy with Doxorubicin-Loaded Reduced Albumin Nanoparticles and Focused Ultrasound in Mouse Breast Cancer Xenografts
by: Daehyun Kim, et al.
Published: (2020-09-01)

A comparison between liposomal and nonliposomal formulations of doxorubicin in the treatment of cancer: An updated review
by: Yik Hoe Ngan, et al.
Published: (2016-01-01)

Moving forward with new data and approaches: a fresh look at anthracyclines in non-Hodgkin’s lymphoma
by: Dino Amadori
Published: (2011-10-01)

Prospective Trial of Neutrophil/Lymphocyte Ratio and Other Blood Counts as Biomarkers of Survival among Patients with High-Grade Soft Tissue Sarcomas Treated with Pegylated Liposomal Doxorubicin and Ifosfamide
by: Keith M. Skubitz, et al.
Published: (2022-07-01)

A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx ® in advanced breast cancer
by: Yinjuan Li, et al.
Published: (2022-12-01)

Morphological changes of doxorubicin-loaded liposomes observed by atomic force microscopy
by: Naoki Takahashi, et al.
Published: (2016-02-01)

A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines
by: Fateme Haghiralsadat, et al.
Published: (2017-05-01)

Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
by: Singh S
Published: (2018-03-01)

Doxorubicin Loaded Liposomal Nanoparticles Containing Quantum Dot for Treatment of Breast Cancer
by: Javad Shahabi, et al.
Published: (2019-10-01)

Imaged-guided focused ultrasound in combination with various formulations of doxorubicin for the treatment of diffuse intrinsic pontine glioma
by: Rianne Haumann, et al.
Published: (2022-04-01)

Fabrication of Doxorubicin-Loaded Lipid-Based Nanocarriers by Microfluidic Rapid Mixing
by: Chia-Ying Lee, et al.
Published: (2022-05-01)

Evading Doxorubicin-Induced Systemic Immunosuppression Using Ultrasound-Responsive Liposomes Combined with Focused Ultrasound
by: Jeongjin Lee, et al.
Published: (2022-11-01)

Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models
by: Vinod Burade, et al.
Published: (2017-06-01)

Histopathological effects of doxorubicin on pancreas in male albino rats
by: I.A. Ali, et al.
Published: (2015-06-01)

PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study
by: Shirleide Santos Nunes, et al.
Published: (2022-01-01)

Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma
by: Wi TI, et al.
Published: (2020-10-01)

Preparation, Physicochemical Properties, and In Vitro Toxicity towards Cancer Cells of Novel Types of Arsonoliposomes
by: Paraskevi Zagana, et al.
Published: (2020-04-01)

A decade's worth of impact: Dox loaded liposomes in anticancer activity
by: Puja Ghosh, et al.
Published: (2022-12-01)

An Open-Label Study of Pegylated Liposomal Doxorubicin, Vincristine, and Reduced-Dose Dexamethasone Combination Therapy in Newly Diagnosed Multiple Myeloma Patients in the Chinese Population
by: Yang SHEN, Zhixiang SHEN, Bin JIANG, et al.
Published: (2009-12-01)

The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer
by: M V Cherkasova, et al.
Published: (2013-12-01)

Chemotherapeutic activity of Silymarin combined with doxorubicin liposomes in 4T1 breast cancer cells
by: Fatemeh Gheybi, et al.
Published: (2019-02-01)

Recurrent Meningioma of the Cervical Spine, Successfully Treated with Liposomal Doxorubicin
by: William L. Read, et al.
Published: (2017-07-01)

Conventional treatments and non-PEGylated liposome encapsulated doxorubicin for visceral leishmaniasis: A scoping review
by: Soumya Ranjan Satapathy, et al.
Published: (2022-01-01)

Neoadjuvant Combination Chemotherapy with Pegylated Liposomal Doxorubicin and Vinorelbine for Locally Advanced Breast Cancer
by: Zhen-zhou SHEN, et al.
Published: (2010-02-01)

Modulated Electro-Hyperthermia Accelerates Tumor Delivery and Improves Anticancer Activity of Doxorubicin Encapsulated in Lyso-Thermosensitive Liposomes in 4T1-Tumor-Bearing Mice
by: Kenan Aloss, et al.
Published: (2024-03-01)

PEGylated Liposomal Doxorubicin Rechallenge following Doxorubicin-induced Pancreatitis
by: Luke Ardolino, et al.
Published: (2020-12-01)

Recent Preclinical and Clinical Progress in Liposomal Doxorubicin
by: Kenan Aloss, et al.
Published: (2023-03-01)

Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: A single-center retrospective real-world data
by: Sibel Oyucu Orhan, et al.
Published: (2021-12-01)

Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
by: Alberto Gabizon, et al.
Published: (2023-11-01)

Maleimide-Functionalized Liposomes: Prolonged Retention and Enhanced Efficacy of Doxorubicin in Breast Cancer with Low Systemic Toxicity
by: Chuane Tang, et al.
Published: (2022-07-01)

A Novel Diosgenin-Based Liposome Delivery System Combined with Doxorubicin for Liver Cancer Therapy
by: Lixia Chen, et al.
Published: (2022-08-01)

Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies
by: Hamidreza Dorostkar, et al.
Published: (2023-07-01)

Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review
by: Mihad Ibrahim, et al.
Published: (2022-01-01)

Evaluation of acute toxicity and in vitro antitumor activity of a novel doxorubicin-loaded folate-coated pH-sensitive liposome
by: Juliana de Oliveira Silva, et al.
Published: (2023-09-01)

Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma
by: Mohammad Mashreghi, et al.
Published: (2020-05-01)

Liposome-Fe3 O4-Doxorubicin Mediated Treatment of Melanoma Tumors
by: Azalia Azlegini, et al.
Published: (2023-03-01)

Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes
by: Beatrice Formicola, et al.
Published: (2019-12-01)